EXTL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.426200E-01
Normal-vs-Stage2
6.207400E-01
Normal-vs-Stage3
6.143400E-01
Normal-vs-Stage4
4.356600E-01
Stage1-vs-Stage2
5.721600E-01
Stage1-vs-Stage3
5.766000E-01
Stage1-vs-Stage4
2.994200E-01
Stage2-vs-Stage3
7.715000E-01
Stage2-vs-Stage4
6.650200E-02
Stage3-vs-Stage4
1.782620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.913200E-01
Normal-vs-AfricanAmerican
7.771200E-01
Normal-vs-Asian
4.043600E-01
Caucasian-vs-AfricanAmerican
8.435000E-01
Caucasian-vs-Asian
2.404000E-01
AfricanAmerican-vs-Asian
3.540200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.957600E-01
Normal-vs-Female
8.456200E-01
Male-vs-Female
1.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.025000E-01
Normal-vs-Age(41-60Yrs)
9.409000E-01
Normal-vs-Age(61-80Yrs)
6.277800E-01
Normal-vs-Age(81-100Yrs)
5.739400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.538800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.959200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.539800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.148500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.264600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.713180E-01
Normal-vs-Daily Drinker
1.859610E-01
Normal-vs-Weekly Drinker
9.758800E-01
Normal-vs-Occasional Drinker
9.316400E-01
Normal-vs-Social Drinker
8.767800E-01
Non Drinker-vs-Daily Drinker
9.717400E-01
Non Drinker-vs-Weekly Drinker
7.146200E-02
Non Drinker-vs-Occasional Drinker
4.790400E-02
Non Drinker-vs-Social Drinker
7.281900E-02
Daily Drinker-vs-Weekly Drinker
4.380400E-02
Daily Drinker-vs-Occasional Drinker
5.065900E-02
Daily Drinker-vs-Social Drinker
7.448200E-02
Weekly Drinker-vs-Occasional Drinker
9.169400E-01
Weekly Drinker-vs-Social Drinker
8.112200E-01
Occasional Drinker-vs-Social Drinker
8.808000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.731200E-01
Normal-vs-Grade 2
9.627800E-01
Normal-vs-Grade 3
9.648400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.670300E-02
Grade 1-vs-Grade 3
2.481800E-01
Grade 1-vs-Grade 4
8.731200E-01
Grade 2-vs-Grade 3
9.737400E-01
Grade 2-vs-Grade 4
9.627800E-01
Grade 3-vs-Grade 4
9.648400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.823000E-01
Normal-vs-NonDiabetic
5.997800E-01
Diabetic-vs-NonDiabetic
6.529800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.360200E-01
Normal-vs-NoPancreatitis
6.370800E-01
Pancreatitis-vs-NoPancreatitis
8.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.072600E-01
Normal-vs-N1
6.350000E-01
N0-vs-N1
7.424000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.872800E-01
Normal-vs-TP53-NonMutant
5.881400E-01
TP53-Mutant-vs-TP53-NonMutant
4.988200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
